PCM Spring Exam Material

  1. Anemia
  2. General Approaches to Anemia- Hematocrit < 41% in males, <37% in females
  3. Iron Deficiency Anemia
  4. Essentials of Diagnosis:
  5. Both pathognomonic; absent bone marrow iron stores or serum ferritin < 12ug/L
  6. Caused by bleeding in adults unless proved otherwise
  7. Response to iron therapy
  8. General Considerations: Causes- Deficient iron, decreased absorption, increased requirements (Pregnancy, lactation), blood loss (GI, menstrual, donation), hemoglobinuria, iron sequestration (pulmonary hemosiderosis)
  9. Clinical Findings
  10. S/S:
  11. Easily fatigability, tachycardia, palpitations and tachypnea on exertion
  12. Severe deficiency: Skin and mucosal changes (smooth tongue, brittle nails, and cheilosis)
  13. Dysphagia: formation of esophageal webs (Plummer-Vinson syndrome)
  14. Pica: craving for specific foods- ice chips, lettuce, etc
  15. Labs:
  16. Hypochromic microcytic cells on smear
  17. Low serum ferritin <30ug/L
  18. Increase in total iron binding capacity
  19. Differential Diagnosis
  20. Anemia of chronic disease: Normal or ↑ iron stores, normal or ↑ ferritin levels, serum iron is low, TIBC is low or normal
  21. Thalassemia: Family hx., microcytosis
  22. Sideroblastic anemia
  23. Treatment
  24. Iron replacement: Oral or parenteral iron
  25. ID cause
  26. Anemia of Chronic Disease
  27. Clinical Findings:
  28. Patient with known chronic disease
  29. Low serum iron, low TIBC, and normal or increased serum ferritin
  30. If severe: Suspect co-existing Fe deficiency or folic acid deficiency
  31. Labs: Normal MCV, Normal blood smear
  32. Treatment:
  33. Usually none
  34. Combinant erythropoietin
  35. Vitamin B12 Deficiency
  36. Essentials of Diagnosis:
  37. Macrocytic anemia
  38. Macro-ovalocytes and hypersegmented PMN on peripheral smear
  39. Serum vit B12 levels < 100pg/mL
  40. General Considerations: Causes- Dietary deficiency (RARE-see only in vegans), Decreased production of IF (pernicious anemia, gastrectomy), H. pylori infection, competition for vit. B12 in gut (Blind loop syndrome, fish tapeworm-rare), Pancreatic insufficiency, Decreased ileal absorption of vit. B12 (Surgical resection, Crohn’s), Transcobalamin II deficiency (rare)
  41. Clinical Findings:
  42. S/S:
  43. Glossitis, anorexia, diarrhea,
  44. Complex neurological syndrome (peripheral neuropathy, impairment of posterior columns, difficulty with balance), dementia, decreased vibration and position sense
  45. Pale, mildly icteric
  46. Labs: Megaloblastic anemia, hematocrits as low as 10-15%
  47. DDx: Folic acid deficiency, myelodysplasia, nonhematologic pernicious anemia
  48. Treatment: Parenteral therapy- IM injection of vit. B12; oral cobalamin
  49. Folic Acid Deficiency
  50. Essentials of Diagnosis:
  51. Macrocytic anemia
  52. Macro-ovalocytes and hypersegmental PMN on peripheral smear
  53. Normal serum vit. B12 levels
  54. Reduced folate levels in RBC of serum
  55. General Considerations: Causes- Dietary deficiency, decreased absorption (Tropical sprue, drugs), increased requirement (chronic hemolytic anemia, pregnancy, exfoliative skin disease), loss (dialysis), inhibition of reduction to active form (MTX)
  56. Clinical Findings
  57. Similar to vit. B12- NO neurological changes
  58. Megaloblastic anemia
  59. Megaloblastic changes in mucosa
  60. DDx: Vit. B12 deficiency, Alcoholic (anemia of liver disease), hypothyroidism
  61. Treatment: Folic acid
  62. Hemolytic Anemia
  63. Sickle Cell Anemia and related syndromes
  64. Essentials of diagnosis:
  65. Irreversibly sickled cells on peripheral blood smear
  66. Positive family history and lifelong history of hemolytic anemia
  67. Recurrent painful episodes
  68. Hemoglobin S is the major hemoglobin seen on electrophoresis
  69. Clinical Findings:
  70. Chronic hemolytic anemia: jaundice, pigment gallstones, splenomegaly-initially, and poorly healing ulcers over lower tibia
  71. Enlarged heart: hyperdynamic precordium and systolic murmurs
  72. Hemolytic crisis- splenic sequestration
  73. Aplastic crisis
  74. Vaso-occlusive crisis: acute painful episodes with low-grade fever, provoked by infection, dehydration, or hypoxia; last hours to days
  75. Prone to delayed puberty
  76. Prone to infections: hyposplenism
  77. Labs: Peripheral blood smear, CBC, hematocrit, Sickledex
  78. Treatment: Folic acid supplements, transfusion for crisis, treat precipitating conditions, kept well hydrated and oxygenated; Hydroxyurea for vaso-occlusive crisises
  79. Aplastic Anemia
  80. Essentials of Diagnosis
  81. Pancytopenia
  82. No abnormal cells seen
  83. Hypocellular bone marrow
  84. Genral Considerations: Causes- Congenital (rare), Idiopathic, SLE, Chemo, radiation, Toxins (benzene, toluene, insecticides), drugs, posthepatitis, pregnancy, paroxysmal nocturnal hemoglobinuria
  85. Clinical Findings:
  86. S/S:
  87. Bone marrow failure  weakness, fatigue, neutropenia (bacterial infections), thrombocytopenia (mucosal and skin bleeds)
  88. PE: Pallor, purpura, petechiae
  89. NOT present: Hepatosplenomegaly, lymphadenopathy, or bone tenderness
  90. Labs: CBC, blood smear, bone marrow aspirate
  91. DDx: Myelodysplatic disorders or acute leukemia
  92. Treatment: Supportive care, RBC and platelet transfusion, antibiotics for infections, BMT, If BMT is not possible: immunosuppression with antithymocyte globulin plus cyclosporine
  93. Geriatric SKIP
  94. Kidney Disease
  95. Glomerulonephritis 872-873
  96. Essentials of Diagnosis
  97. Hematuria, dysmorphic red cells, red cell casts, and mild proteinuria
  98. Dependent edema and hypertension
  99. Acute renal insufficiency
  100. General Considerations: Uncommon cause of acute renal failure
  101. Clinical Findings
  102. HTN, edema (first peri-orbital and scrotal), abnormal sediment
  103. Labs: Hematuria, moderate proteinuria, cellular elements
  104. Treatment: Depends on severity: high dose CST and cytotoxic agests; plasma exchange for Goodpasture’s
  105. Nephritic Syndrome
  106. Essentials of Diagnosis
  107. Edema
  108. HTN
  109. Hematuria (w/ or w/o dysmorphic red cells, red cell casts)
  110. General Considerations: Rapidly progressive acute GN can cause permanent damage to glomeruli
  111. Clinical Findings:
  112. S/S: Edema (first peri-orbital and scrotal), HTN (due to volume overload)
  113. Labs: Serum: Complement levels, ANA, cryoglobulins, hepatitis panels, ANCA, anti-GBM ab, ASO titers, and C3 nephritic factors; Urinalysis; Biopsy
  114. Treatment: Reduce HTN and fluid overload; therapeutic management of underlying cause; Salt and water restriction, diuretic therapy, dialysis if needed; may require CST and cytotoxic agents
  115. Hypertension
  116. Management of Hypertension
  117. Etiologies and Classifications
  118. Primary (85%): Onset between 25-55 yo; early in course BP fluctuates
  119. Classification:
  120. Optimal: <120/<80
  121. Normal: <130/<85
  122. High-normal: 130-139/85-90
  123. HTN Stage 1: 140-159/90-99
  124. HTN Stage 2: 160-179/100-109
  125. HTN Stage 3: >180/>110
  126. Factors involved in pathogenesis: genetics, hyperactive sympathetic NS, renin-angiotension system, defect in natriuresis, intracellular Na and Ca (both increased)
  127. Risk factors: obesity, sodium intake, alcohol, smoking, exercise, polycythemia, NSAID (increase), potassium intake (low intake associated with higher BP)
  128. Secondary
  129. Estrogen use
  130. Renal Disease
  131. Renal vascular HTN
  132. Primary hyperaldosteronism and Cushing’s
  133. Pheochromocytoma
  134. Coarctation of the aorta
  135. HTN associated with pregnancy
  136. Complications of untreated HTN (due to sustained elevated BP  changes in vasculature and heart)
  137. HTN cardiovascular disease
  138. HTN cerebrovascular disease and dementia (stroke)
  139. HTN renal disease
  140. Aortic dissection
  141. Atherosclerotic complication
  142. Clinical Findings: Asymptomatic
  143. HA: suboccipital pulsating HA that are worse in the morning
  144. Accelerated HTN: somnolence, confusion, visual disturbances, nausea and vomiting
  145. Pheochromocytoma: Sustained HTN or episodic HTN; attacks of anxiety, palpitations, profuse perspiration, pallor, tremor, nausea and vomiting; markedly elevated BP; angina and acute pulmonary edema may occur
  146. Primary aldosteronism: Muscular weakness, polyuria, and nocturia due to hypokalemia; malignant HTN is RARE; chronic HTN  ventricular hypertrophy; exertional and paroxysmal nocturnal dyspnea
  147. Cerebral involvement: Stroke due to thrombosis or small or large hemorrhage from microaneurysms; HTN encephalopathy
  148. Signs:
  149. BP – take in both arms and lower extremities if pulse is absent, orthostatic
  150. Retinas: Narrowing of arterial diameter, exudates, hemorrhages, or papilledema
  151. Heart and arteries: Systolic ejection murmurs from calcified aortic sclerosis
  152. Pulses: Compare upper and lower extremities
  153. Nonpharmacologic Therapy
  154. DASH diet, weight reduction, reduce alcohol, reduce salt, gradual increase in exercise, smoking cessation
  155. Who should be treated with medication
  156. Patients in stage II or III
  157. Patients that are high normal or stage I are treated with drugs if they have certain risk factors
  158. Goals of Treatment: Reduce cardiovascular risk and further complications
  159. Drug Therapy
  160. Diuretic
  161. β-adrenergic blocking agents
  162. ACE inhibitors
  163. ARB’s
  164. Calcium channel blockers
  165. α-adrenergic receptor blockers
  166. Drugs with central sympatholytic action
  167. Arteriolar dilators
  168. Peripheral sympathetic inhibitors
  169. Hyponatremia and Hypernatremia
  170. Approach to the Patient:
  171. Volume overload: Increased weight, peripheral edema, ascites
  172. Volume depletion: Weight loss, excessive thirst, dry mucous membranes
  173. Dehydration: Pure water deficit
  174. Hyponatremia
  175. Essentials of Diagnosis
  176. Extracellular fluid and serum osmolality are important determinants of etiology
  177. Most cases result from water imbalance, not sodium imbalance
  178. Urine sodium:
  179. If > 20 meq/L: Renal salt wasting
  180. If < 10meq/L: Avid sodium retention due to extrarenal Sodium wasting
  181. Isotonic Hyponatremia: Hyperlipidemia and hyperproteinemia  displaces water  Decreased sodium conc. In total plasma volume
  182. Hypertonic Hyponatremia: Seen with hyperglycemia, water drawn from cells into extracellular space when blood glucose is high. Increase in glucose causes drop in sodium.
  183. Hypotonic Hyponatremia: Retention of electrolyte-free water due to impaired excretion
  184. Hypovolemic hypotonic hyponatremia: Renal or extrarenal volume loss ADH excretion  Free water retention
  185. Euvolemic Hypotonic Hyponatremia:
  186. SIADH
  187. Hypothyroidism- not common; water retention
  188. Psychogenic polydispia and beer potomania: Marked excess of free water intake
  189. Idiosyncratic diuretic reaction: Euvolemic patients on diuretics  xs renal sodium loss and water retention
  190. Idiosyncratic ACE inhibitor reactions: Central polydipsia and increased ADH secretion
  191. Endurance exercise hyponatrium: Xs fluid overload and continued ADH secretion
  192. Mineralcorticoid-responsive hyponatremia in elderly
  193. Treatment
  194. Treat underlying cause and Water restriction
  195. Diuretics
  196. Hypertonic saline: NOT usually recommended
  197. Hyponatremia in AIDS: Associated with pneumonia and CNS processes; euvolemic SIADH
  198. Hypernatremia
  199. Essentials of Diagnosis
  200. Occurs most commonly when water intake or water supplementation is inadequate
  201. Urine osmolality helps differentiate renal from nonrenal water loss
  202. Clinical Findings
  203. S/S: Orthostatic hypotension, oliguria are common. Hyperthermia, delirium, and coma with severe hyperosmolality
  204. Labs:
  205. Urine osmolality > 400 mosm/kg – renal water-conserving ability is functioning: Renal vs. non-renal losses
  206. Urine osmolality < 250 mosm/kg – Dilute urine with hypernatremia is characteristic of central and nephrogenic diabetes insipidus
  207. Treatment:
  208. With hypovolemia: Isotonic saline
  209. With Euvolemia: Drink water, 5% dextrose and water IV
  210. With hypervolemia: 5% dextrose in water + loop diuretic
  211. Renal Calculi
  212. Urinary Stone Disease
  213. Clinical Finding: Colic pain, localized to flank, associated with nausea and vomiting (in constant motion), radiate anteriorly over abdomen; if lodged at ureterovesical junction causes urinary urgency and frequency.
  214. Labs: Serum calcium, phosphate, electrolytes, and uric acid. Urinalysis, plain film and renal U/S, spiral CT
  215. Medical Treatment and Prevention
  216. Increased fluid intake
  217. Sleep stone side down
  218. Surgical treatment: Ureteroscopic stone extraction; shock wave lithotripsy – external energy source fragment stone and lets it pass (not good for women of childbearing age)
  219. Benign Prostatic Hyperplasia
  220. Essentials of Diagnosis:
  221. Obstruction or irritative voiding symptoms
  222. May have enlarged prostate on rectal examination
  223. Absence of urinary tract infection, neurologic disorders, stricture disease, prostatic or bladder malignancy
  224. General Consideration: Older men, genetics (?), DHT sensitivity
  225. Clinical Findings:
  226. Obstructive: hesitancy, decreased force and caliber of the stream, sensation of incomplete bladder emptying, double voiding, straining to urinate, and postvoid dribble
  227. Irritative: Urgency, frequency, and nocturia
  228. Questions to ask:
  229. Over last month, how often have you had the sensation of not completely emptying your bladder after finishing urination?
  230. How often have you had to urinate again less than 2 hrs after you finish urinating?
  231. How often have you found you stopped and started again several times when you urinated?
  232. How often have you found it difficult to postpone urination?
  233. How often have you had a weak urine stream?
  234. How often have you had to push or strain to begin urination?
  235. How many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning?
  236. Signs: PE, DRE, and focused neurological exam on all patients, lower abdomen examination (assess fullness of bladder)
  237. Labs: PSA, urinalysis, electrolyte panel
  238. DDx: Prostatic carcinoma, renal insufficiency, UTI, urethral stricture, bladder stone
  239. Treatment: Mild symptoms: Watchful waiting; Absolute surgical indications are refractory urinary retention; MEDS: α-blocker, 5α-Reductase inhibitors, combination therapy, phytotherapy; Surgery: TURP
  240. Menopause
  241. Menopausal Syndrome
  242. Essentials of Diagnosis:
  243. Cessation of menses due to aging or to bilateral oophorectomy
  244. Elevation of FSH and LH levels
  245. Hot flushes and night sweats
  246. Decreased vaginal lubrication; thinned vaginal mucosa with or without dyspareunia
  247. Clinical Findings:
  248. Menstrual cycles become irregular and longer, menopause occurs when menstruation has not occurred for one year;
  249. Hot flushes; vaginal atrophy (decreased introitus, vaginal dryness, pale, smooth vaginal mucosa, small cervix and uterus); osteoporosis
  250. Labs: Elevated serum FSH and LH; Vaginal cytology: Parabasal cell (loss of maturation due to hypoestrinism)
  251. Treatment: Education; vasomotor symptoms: HRT (mention risks); vaginal atrophy: HRT, estradiol vaginal ring, short-term use of estrogen vaginal cream; Osteoporosis: Calcium fortified foods (1000mg per day + vit D)
  252. Primary Amenorrhea- >14 yo, no breast development, height in lowest 3%; or greater than 16 with no menstruation
  253. Etiology:
  254. Hypothalamic-pituitary causes: Low-normal FSH
  255. Hyperandrogenism: Low-normal FSH
  256. Ovarian causes: High FSH; Turners, AI
  257. Pseudohermaphroditism: High LH
  258. Uterine Causes: Normal FSH
  259. Pregnancy: High hCG
  260. Clinical Findings: Hx. and PE
  261. HA or visual field abnormalities implicate a hypothalamic or pituitary tumor;
  262. Signs of pregnancy;
  263. BP abnormalities, acne, and hirsutism should be noted;
  264. Short stature with gonadal dysgenesis indicates Turner’s syndrome;
  265. Olfaction testing for Kallmann’s syndrome;
  266. Obesity and short stature may be a sign of Cushing’s;
  267. Tall stature may be due to eunuchoidism or gigantism;
  268. Hirsutism or virilization suggest excessive testosterone;
  269. external pelvic exam – assess hymenal patency and presence of uterus
  270. LABS: Serum FSH, LH, PRL, testosterone, TSH, free T4, and hCG
  271. Treatment: Directed at the underlying cause
  272. Secondary Amenorrhea and Menopause
  273. Etiology:
  274. Pregnancy: High hCG
  275. Hypothalamic-Pituitary Cause: Low-normal FSH
  276. Hyperandrogenism: Low-normal FSH
  277. Uterine Causes: Normal FSH
  278. Premature Ovarian Failure: High FSH
  279. Menopause: High FSH
  280. Clinical Findings: Hx and PE
  281. Nausea and breast engorgement: pregnancy
  282. Hot flushes: Ovarian failure
  283. HA or visual field abnormalities: Pituitary or hypothalamic tumor
  284. Thirst, polyuria: diabetes insipidus  hypothalamic lesion
  285. Goiter: Hyperthyroidism
  286. Weight loss, diarrhea, or skin darkening: Adrenal insufficiency
  287. Weight loss and distorted body image: Anorexia
  288. Galactorrhea: hyperprolactenemia
  289. Hirsutism or virilization suggest excessive testosterone
  290. Hypercortisolism: Alcohol or Cushings
  291. Acromegaly, gigantism: pituitary tumor
  292. Systemic illness, drugs
  293. Pelvic exam: uterine and adnexal enlargement, PAP, vaginal smear
  294. LABS: Serum hCG, testosterone, PRL, FSH, LH, TSH, plasma K; renal and liver panel
  295. Treatment: Directed at cause. HRT can relieve symptoms. If labs are normal and not pregnant: 10d course of progestin
  296. Diabetes
  297. Essentials of Diagnosis:

TYPE 1 DIABETES

  1. Polyuria, polydispia, and weight loss associated with random plasma glucose > 200 mg/dl
  2. Plasma glucose of 126 mg/dl or higher after an overnight fast, documented on more than one occasion
  3. Ketonemia, ketonuria, or both

TYPE 2 DIABETES

  1. Most patients are over 40 yo and obese
  2. Polyuria and polydipsia. Ketonuria and weight loss generally are uncommon at time of diagnosis. Candidal vaginitis in women may be an initial manifestation. Many patients have few or no symptoms
  3. Plasma glucose of 126 mg/dl or higher after an overnight fast on more than one occasion. After 75 g oral glucose, diagnostic values are 200 mg/dl or more 2 hrs after oral glucose.
  4. HTN, dyslipidemia, and atherosclerosis are often associated
  1. Clinical Findings:

Type 1 Diabetes / Type 2 Diabetes
Polyuria and thirst / ++ / +
Weakness or fatigue / ++ / +
Polyphagia with weight loss / ++ / -
Recurrent blurred vision / + / ++
Vulvovaginitis or pruritus / + / ++
Peripheral neuropathy / + / ++
Nocturnal enuresis / ++ / -
Often asymptomatic / - / ++
  1. Labs:
  2. Urinalysis: Glucosuria, ketonuria
  3. Blood testing procedures: Glucose tolerance test, glycated hgb, serum fructosamine, self-monitoring of blood glucose, continuous glucose monitoring system, lipoprotein abnormalities in diabetes
  4. DDx.: Hyperglycemia secondary to other causes (Cushing’s, CST, acromengaly, liver disease, muscle disorders…); Non-diabetic glycosuria
  5. Goals of Treatment: Pt. ed, restore known metabolic derangements toward normal in order to prevent and delay progression of diabetic complications
  6. Treatment: Pt. ed, diet, oral agents, insulin
  1. Diseases of the Thyroid
  2. Tests of Thyroid Function: TSH (most sensitive), free T4; thyroid radioactive iodine uptake and scan
  3. Hypothyroidism and Myxedema
  4. Essentials of Diagnosis
  5. Weakness, fatigue, cold intolerance, constipation, weight change, depression, menorrhagia, hoarseness
  6. Dry skin, bradycardia, delayed return of deep tendon reflexes
  7. Anemia, hyponatremia
  8. T4 and radioiodine uptake usually low
  9. TSH elevated in primary hypothyroidism
  10. Clinical Findings:
  11. Early: Fatigue, lethargy, weakness, arthralgias or myalgias, muscle cramps, cold intolerance, constipation, dry skin, HA, and menorrhagia PE: Thin, brittle nails, thinning of hair, and pallor, poor mucosa turgor, decreased return of deep tendon reflexes
  12. Late: Slow speech, absence of sweating, constipation, peripheral edema, pallor, hoarseness, decreased sense of taste and smell, muscle cramps, aches and pains, dyspnea, weight changes, diminished auditory acuity PE: goiter, puffiness of face, carotenemic skin color, thinning of outer eyebrows, thickening of tongue, hard pitting edema, effusions
  13. Labs: Free T4: normal to low; TSH: increased in primary, low or normal in pituitary insufficiency; Lipid panel (increased cholesterol), increased liver enzymes, CK…
  14. DDx: Unexplained heart failure, primary amyloidosis, pernicious anemia, depression
  15. Complications: Mostly cardiac (advanced CAD), megacolon, increased susceptibility to infection, organic psychoses, rarely causes infertility, miscarriage, can progress to myxedema coma
  16. Treatment: Thyroid replacement therapy, usually T4; reassess T4 levels regularly
  17. Hyperthyrodism
  18. Essentials of Diagnosis
  19. Sweating, weight loss or gain, anxiety, loose stools, heat intolerance, irritability, fatigue, weakness, menstrual irregularities
  20. Tachycardia; warm, moist skin; stare; tremor
  21. In Grave’s disease: goiter, ophthalmopathy
  22. Suppressed TSH in primary hyperthyroidism; increased T4, free T4 and free T4 index
  23. General Considerations: Grave’s disease, Toxic adenomas, subacute thyroiditis, jodbasedow disease (iodine-induced hyperthyroidism), thyrotoxicosis factitia, struma ovarii, pituitary tumor, hashimoto’s thyroiditis, pregnancy and trophoblastic tumors, thyroid carcinoma, amiodarone-induced thyrotoxicosis
  24. Clinical Findings: SEE Essentials of Diagnosis; LABS: T4 an TSH levels, serum TSH receptor antibody, serum ANA and anti-dsDNA, sedimentation rate, thyroid radioactive iodine uptake and scan
  25. DDx: Anxiety, mania, acute psychiatric disorder, cardiac disease, hypermetabolism (pheochromocytoma), diabetes, Addison’s
  26. Complications: Cardiac complication, periodic paralysis w/ exercise or heavy carb intake, hypercalcemia, osteoporosis, and nephrocalcinosis
  27. Treatment: Depends on cause
  28. Graves: Propanol for sympathetic relief, thiouria drug, methimazole, propylthiouracil, iodinated contrast agents, radioactive iodine (destroys active thyroid tissue)- not to pregnant women
  29. Metabolic Bone Disease
  30. Osteoporosis
  31. Essentials of Diagnosis
  32. Asymptomatic to severe backache from vertebral fractures
  33. Spontaneous fractures often discovered incidentally on radiography; loss of height
  34. Serum parathyroid hormone, 25(OH)D2, Ca, phosphorous, and alkaline phosphatase usually normal
  35. Demineralization, esp. of spine, hip, and plevis
  36. Etiology
  37. Hormonal deficiency: Estrogen, androgen
  38. Hormonal Excess: Glucocorticoid, thyrotoxicosis, hyperparathyroidism
  39. Immobilization, microgravity
  40. Tobacco, Alcoholism
  41. Malignancy, esp multiple myeloma
  42. Meds: xs.